Literature DB >> 16077324

Pigmented villonodular synovitis of the temporomandibular joint.

Piero Cascone1, Claudio Rinna, Claudio Ungari, Giulio Poladas, Poladas Giulio, Fabio Filiaci.   

Abstract

Pigmented villonodular synovitis (PVNS) is a relatively rare disease, affecting the synovial-lined joints. PVNS was first fully described by Jaffè in 1941, who considered it to be a benign inflammatory state of the synovium of an uncertain etiology. Reports of this disease in the temporomandibular joint (TMJ) are extremely rare. The authors report a case of a 38-year-old woman affected by pigmented villonodular synovitis of the TMJ. Clinical examination revealed the presence of a preauricular mass in the left side; a computed tomography scan showed a 3.0 x 2.0 cm preauricular mass in close continuity to the TMJ capsule. The purpose of this report is to describe the clinicopathological features of a case involving the TMJ. The previously reported cases in the literature are also reviewed.

Entities:  

Mesh:

Year:  2005        PMID: 16077324     DOI: 10.1097/01.scs.0000159085.67672.2d

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

1.  Diagnosis and treatment of synovial chondromatosis of the TMJ: a clinical case.

Authors:  Valentino Valentini; Paolo Arangio; Sara Egidi; Marco Capriotti; Valentino Vellone; Marco Castrechini; Marco Costrechini; Giulio Boschi; Piero Cascone; Vincenzo Calafati; Umberto Torre; Irma Ricciardi
Journal:  Ann Stomatol (Roma)       Date:  2014-02-04

2.  Pigmented villonodular synovitis of the temporomandibular joint - computed tomography and magnetic resonance findings: a case report.

Authors:  Il-Kyu Kim; Hyun-Young Cho; Hyun-Woo Cho; Ji-Hoon Seo; Dong-Hwan Lee; Wang Peng
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-06-27

3.  Case Report: Extra-Articular Diffuse Tenosynovial Giant Cell Tumor of the Temporomandibular Joint.

Authors:  Xibiao Yang; Li Yao; Tianping Yu; Xiaoli Du; Qiang Yue
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.